JPS61226061A - Catheter stayed in blood vessel - Google Patents
Catheter stayed in blood vesselInfo
- Publication number
- JPS61226061A JPS61226061A JP60067269A JP6726985A JPS61226061A JP S61226061 A JPS61226061 A JP S61226061A JP 60067269 A JP60067269 A JP 60067269A JP 6726985 A JP6726985 A JP 6726985A JP S61226061 A JPS61226061 A JP S61226061A
- Authority
- JP
- Japan
- Prior art keywords
- catheter
- resin
- blood vessel
- hollow fiber
- hollow fibers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は輸液を血管内に持続的に注入するための血管内
留置カテーテルに関するものである。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to an intravascular indwelling catheter for continuously injecting an infusion into a blood vessel.
(従来の技術と問題点)
近年、高齢者や低栄養状態の患者の治療に高張カロリー
輸液が盛んに行われている。かかる治療には両端開口チ
ューブ体と、該チューブ体の一端に固着されたハブとか
らなる血管内留置カテーテルが使用される。このカテー
テルは先端が輸液の排出口になっているため輸液をカテ
ーテルを通じて投与する場合カテーテルの排出口部分の
血液と輸液が混合することになる。その結果感染症その
他の合併症、例えば輸液の成分に応じて静脈の刺激が続
いて起り、静脈壊俄の可能性を伴う炎症または浮腫など
が起ることがある。また輸液の高張性に起因する静脈炎
も起ることがある。(Prior Art and Problems) In recent years, hypertonic calorie infusions have been widely used in the treatment of elderly and malnourished patients. For such treatment, an intravascular indwelling catheter consisting of a tube body with open ends and a hub fixed to one end of the tube body is used. This catheter has an infusion outlet at its tip, so when administering an infusion through the catheter, the infusion mixes with blood at the outlet of the catheter. As a result, infections and other complications may follow, such as venous irritation depending on the components of the infusion, inflammation or edema with possible venous rupture. Phlebitis may also occur due to hypertonicity of the infusion.
またこの種のカテーテルに使用されるチューブ体の材料
として天然ゴムやポリ−シス−イソプレンゴム等の合成
ゴム、あるいはポリエチレン、ポリプロピレン、テトラ
フルオロエチレン等の合成樹脂が用いられているが、こ
れらの材料は生体組織との親和性が乏しいため、チュー
ブ表面、特にチューブの排出口で血栓を生じる危険があ
る。In addition, the tube body used in this type of catheter is made of natural rubber, synthetic rubber such as poly-cis-isoprene rubber, or synthetic resin such as polyethylene, polypropylene, or tetrafluoroethylene. Because it has poor affinity with living tissues, there is a risk of thrombus formation on the tube surface, especially at the tube outlet.
(問題点を解決するための手段)
したがって本発明の目的は血栓や感染症などの危険のな
い安全性の高い血管内留IWカテーテルを提供すること
にるる。(Means for Solving the Problems) Therefore, an object of the present invention is to provide an intravascular indwelling IW catheter that is highly safe and free from risks such as thrombosis and infection.
本発明の血管内留置カテーテルは平均孔径0.02〜2
μの多数の微細孔が横断面に実質的に均一に配列された
親水性高分子よりなる中空繊維の先端部を樹脂で閉塞す
るとともに、他端部をハブに固定したことを特徴とする
血管内留置カテーテルである○
(実施例)
次に本発明の血管内留置カテーテルの一実施例を図面に
て説明する。第1図に示すように、本発明のカテーテル
は先端が樹脂3で閉塞され、かつ他端が開口した親水性
を有する中空繊維1と、この中空繊維の開口端部を接着
剤4を介して固着したハブ2で構成されている。The intravascular indwelling catheter of the present invention has an average pore diameter of 0.02 to 2.
A blood vessel characterized in that the tip of a hollow fiber made of a hydrophilic polymer in which a large number of micropores of μ are substantially uniformly arranged in a cross section is closed with a resin, and the other end is fixed to a hub. Internally indwelling catheter (Example) Next, an embodiment of the intravascular indwelling catheter of the present invention will be described with reference to the drawings. As shown in FIG. 1, the catheter of the present invention includes a hydrophilic hollow fiber 1 whose tip end is closed with a resin 3 and whose other end is open, and the open end of the hollow fiber is connected with an adhesive 4. It consists of a fixed hub 2.
この親水性を有する中空線維1とはポリビニルアルコー
ル、エチレンビニルアルコール共重合体、ポリヒドロキ
シエチルメタクリレートおよびこれら各高分子をグルタ
ルアルデヒド、ホルムアルデヒド等で反応させたもの、
あるいはポリアセチルセルロース、ポリアクリロニトリ
ル等の親水性高分子よりなる中空繊維、あるいはポリプ
ロピレン、=3−
ポリテトラフロロエチレン、ポリエチレン、ポリスチレ
ン、ポリスルホン等の疎水性の高分子からなる中空繊維
の表面を親水化処理したものである。This hydrophilic hollow fiber 1 is made by reacting polyvinyl alcohol, ethylene vinyl alcohol copolymer, polyhydroxyethyl methacrylate, and each of these polymers with glutaraldehyde, formaldehyde, etc.
Alternatively, the surface of hollow fibers made of hydrophilic polymers such as polyacetylcellulose and polyacrylonitrile, or hollow fibers made of hydrophobic polymers such as polypropylene, 3-polytetrafluoroethylene, polyethylene, polystyrene, and polysulfone, is made hydrophilic. It has been processed.
親水化処理としてはスルホン化等の化学処理及びエタノ
ール、界面活性剤等の処理があげられる。Examples of hydrophilic treatment include chemical treatment such as sulfonation, and treatment with ethanol, surfactants, and the like.
疎水性高分子からなる中空繊維の親水化は、その細孔内
に毛細管現象によって水が自然に吸引きれる程度に親水
化したものをいう。Hydrophilization of hollow fibers made of hydrophobic polymers refers to hollow fibers that have been made hydrophilic to the extent that water can be naturally sucked into their pores by capillary action.
また本発明に用いる中空繊維は平均孔径0.02〜2μ
の微細孔が横断面に実質的に均一に配列されている。実
質的に均一とは膜の厚さ全体にわたりほぼ同一の孔径の
微細孔があるもの、0.02〜2μの範囲で膜の一面か
ら他面に段階的または連続的に径の大きさに変化がある
ものが含まれる。Furthermore, the hollow fibers used in the present invention have an average pore diameter of 0.02 to 2μ.
The micropores are arranged substantially uniformly in the cross section. Substantially uniform means that the membrane has micropores with approximately the same diameter throughout the entire thickness, and the diameter changes stepwise or continuously from one side of the membrane to the other in the range of 0.02 to 2μ. Includes items that have.
かかる中空繊維を用いることにより輸液に含まれる微粒
子あるいは細菌等を除去することができる。By using such hollow fibers, fine particles, bacteria, etc. contained in the infusion can be removed.
中空繊維としては通常50〜3000μ、膜厚10〜5
00μのものが用いられる。Hollow fibers usually have a thickness of 50 to 3000μ and a film thickness of 10 to 5.
00μ is used.
上記中空繊維は通常の紡糸技術によって製造することが
できる。例えばポリビニルアルコール系の中空繊維は特
開昭52−21420号に記載の方法により製造するこ
とができる。The hollow fibers described above can be manufactured by conventional spinning techniques. For example, polyvinyl alcohol-based hollow fibers can be produced by the method described in JP-A-52-21420.
上記中空繊維lの先端開口は樹脂3で閉塞されている。The tip opening of the hollow fiber 1 is closed with resin 3.
この樹脂としては生体適合性を有する樹脂、例えばシリ
コーン樹脂、ポリウレタン樹脂等が用いられる。中空繊
維の他端は接着剤4でハブ2に固着されている。As this resin, biocompatible resins such as silicone resins and polyurethane resins are used. The other end of the hollow fiber is fixed to the hub 2 with an adhesive 4.
上記カテーテルの血管外に露出した部分からの輸液の洩
出を防止するため、その部分の表面を樹脂5で被覆する
ことが好ましい。かかる樹脂としてはポリウレタン、シ
リコーン、ポリヒドロキシエチルメタアクリレートなど
の生体適合性を有する樹脂を用いることが好ましい。カ
テーテルの表面に上記樹脂による被覆層を形成させるに
は、種々の方法を採用できるが、例えば適当な溶剤に溶
解して得られた上述の樹脂溶液をカテーテルに塗るか、
または吹きつけて乾燥したり、上記溶液にカテーテルを
浸漬したのち乾燥する方法などがある〇
一方親水性の大きい中空繊維の場合、透過性に優れるも
の程強度が劣る傾向がある。そのためかかる中空繊維か
らなるカテーテルを使用後、体内よシ取り出す際に中空
繊維が切断し、切断片が体内に残留する恐れがある。上
記切断片の体内への残留を防止するため第2図に示すよ
うに中空繊維1の先端開口を閉塞する樹脂3に糸状体6
の一端を固着して、この糸状体を中空繊維に沿って延在
させ、その他端を中空繊維の内径より大きな径を有する
球状体、あるいは四角状体などの中空繊維の開口端に係
止する部材7に固着することが好ましい。このように中
空繊維の先端開口を閉塞する樹脂に糸状体を固着すると
とによりカテーテル取り出し時に、例え中空繊維が切断
しても切断片を容易に取り出せるようにしている。糸状
体の一端を係止部材7に固着するかわりに、糸状体の一
端をハブの内壁に固着してもよい。上記係止部材7とし
て通常生体適合性を有するポリウレタン樹脂等が用いら
れる。また上記糸状体としては毒性等の生体への影響の
ないものを選択しなければならない。通常ステンレス線
などの金属線、ナイロン、ポリエステル等の合成繊維が
用いられる。上記糸状体としてラセン状の金属線を用い
ると中空繊維の曲げ強度が補強できて好ましい。この場
合にはラセン状金属線の一端を中空繊維の先端を閉塞す
る樹脂3に固着し、他端をハブ2に固着する。In order to prevent leakage of infusion fluid from the portion of the catheter exposed outside the blood vessel, it is preferable to coat the surface of that portion with resin 5. As such a resin, it is preferable to use a biocompatible resin such as polyurethane, silicone, or polyhydroxyethyl methacrylate. Various methods can be used to form a coating layer of the resin on the surface of the catheter, such as applying the resin solution obtained by dissolving it in an appropriate solvent to the catheter,
Alternatively, there are methods such as blow drying or immersing the catheter in the above solution and then drying.On the other hand, in the case of highly hydrophilic hollow fibers, those with excellent permeability tend to have inferior strength. Therefore, after using a catheter made of such hollow fibers, when the catheter is taken out of the body, the hollow fibers may be cut and the cut pieces may remain in the body. In order to prevent the cut pieces from remaining in the body, as shown in FIG.
One end is fixed and the filament is extended along the hollow fiber, and the other end is locked to the open end of the hollow fiber such as a spherical body or a square body having a diameter larger than the inner diameter of the hollow fiber. Preferably, it is fixed to the member 7. By fixing the filamentous body to the resin that closes the opening at the tip of the hollow fiber in this way, even if the hollow fiber is cut when the catheter is taken out, the cut piece can be easily taken out. Instead of fixing one end of the thread to the locking member 7, one end of the thread may be fixed to the inner wall of the hub. As the locking member 7, biocompatible polyurethane resin or the like is usually used. Furthermore, the above-mentioned filamentous body must be selected from one that does not have any effects on living organisms such as toxicity. Usually, metal wires such as stainless steel wires, synthetic fibers such as nylon, polyester, etc. are used. It is preferable to use a helical metal wire as the filamentous body because the bending strength of the hollow fiber can be reinforced. In this case, one end of the helical metal wire is fixed to the resin 3 that closes the tip of the hollow fiber, and the other end is fixed to the hub 2.
上述のカテーテルは第3図に示すように血管10内に留
置される。カテーテルの端部に設けたハブ2には点滴セ
ット(図示せず)の一端が接続され、輸液ボトルからヘ
ッド差により輸液がカテーテル内に導入される。カテー
テル内に導入された輸液は中空繊維の壁膜に形成された
全ての微細孔から血管内に洩出しながら血液中に混入さ
れる。The catheter described above is placed in the blood vessel 10 as shown in FIG. One end of an infusion set (not shown) is connected to a hub 2 provided at the end of the catheter, and infusion fluid is introduced into the catheter from an infusion bottle using a head difference. The infusion fluid introduced into the catheter leaks into the blood vessel through all the micropores formed in the wall of the hollow fibers and mixes into the blood.
(発明の効果)
以上のように本発明の血管留置カテーテルは先端が閉塞
された多孔性の中空繊維を用いているため、輸液は中空
繊維の全面から漏出するので、中空繊維表面で輸液を急
速に希釈することができ、それにより静脈炎の発生率を
低下させることができるとともに、中空繊維の表面に輸
液層が形成されるため血栓形成の危険が減少する。また
中空線維の壁膜の微細孔がフィルターになるので感染も
防止できるという優れた効果を有している。(Effects of the Invention) As described above, since the vascular indwelling catheter of the present invention uses porous hollow fibers with closed tips, the infusion fluid leaks from the entire surface of the hollow fibers, so the infusion fluid is rapidly dispersed on the surface of the hollow fibers. This can reduce the incidence of phlebitis and reduce the risk of thrombus formation due to the formation of an infusion layer on the surface of the hollow fibers. Furthermore, since the micropores in the wall of the hollow fibers act as a filter, it has the excellent effect of preventing infection.
第1図及び第2図は本発明の血管内留層カテーテルの断
面図であり、第3図は本発明のカテーテルの使用状態を
示す説明図である。1 and 2 are cross-sectional views of the intravascular reservoir catheter of the present invention, and FIG. 3 is an explanatory view showing the state of use of the catheter of the present invention.
Claims (1)
実質的に均一に配列された、親水性を有する中空繊維の
先端部を樹脂で閉塞するとともに、他端部をハブに固着
したことを特徴とする血管内留置カテーテル。 2、該中空繊維の血管外に露出する部分の表面を樹脂で
被覆したことを特徴とする特許請求の範囲第1項記載の
血管内留置カテーテル。[Scope of Claims] 1. The tip of a hydrophilic hollow fiber in which a large number of micropores with an average pore diameter of 0.02 to 2 μm are arranged substantially uniformly in the cross section is closed with a resin, and An intravascular indwelling catheter characterized by having an end fixed to a hub. 2. The intravascular indwelling catheter according to claim 1, wherein the surface of the portion of the hollow fiber exposed outside the blood vessel is coated with a resin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60067269A JPS61226061A (en) | 1985-03-29 | 1985-03-29 | Catheter stayed in blood vessel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60067269A JPS61226061A (en) | 1985-03-29 | 1985-03-29 | Catheter stayed in blood vessel |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61226061A true JPS61226061A (en) | 1986-10-07 |
JPH0460674B2 JPH0460674B2 (en) | 1992-09-28 |
Family
ID=13340070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60067269A Granted JPS61226061A (en) | 1985-03-29 | 1985-03-29 | Catheter stayed in blood vessel |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61226061A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996004033A1 (en) * | 1994-08-03 | 1996-02-15 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Microcatheter |
EP1363695A2 (en) * | 2001-03-01 | 2003-11-26 | David A. Watson | Ingrowth preventing indwelling catheter assembly |
US11992627B2 (en) | 2020-06-30 | 2024-05-28 | Access Vascular, Inc. | Articles comprising markings and related methods |
US12194198B2 (en) | 2018-12-19 | 2025-01-14 | Access Vascular, Inc. | High strength porous materials for controlled release |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5931330A (en) * | 1982-05-13 | 1984-02-20 | オ・ウ・オ−ル−プラスト・ア・ボ | Floor drain or other cup-shaped water seal |
-
1985
- 1985-03-29 JP JP60067269A patent/JPS61226061A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5931330A (en) * | 1982-05-13 | 1984-02-20 | オ・ウ・オ−ル−プラスト・ア・ボ | Floor drain or other cup-shaped water seal |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996004033A1 (en) * | 1994-08-03 | 1996-02-15 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Microcatheter |
EP1363695A2 (en) * | 2001-03-01 | 2003-11-26 | David A. Watson | Ingrowth preventing indwelling catheter assembly |
EP1363695A4 (en) * | 2001-03-01 | 2006-05-24 | David A Watson | Ingrowth preventing indwelling catheter assembly |
US12194198B2 (en) | 2018-12-19 | 2025-01-14 | Access Vascular, Inc. | High strength porous materials for controlled release |
US11992627B2 (en) | 2020-06-30 | 2024-05-28 | Access Vascular, Inc. | Articles comprising markings and related methods |
Also Published As
Publication number | Publication date |
---|---|
JPH0460674B2 (en) | 1992-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4874373A (en) | Dip formed catheter and assembly | |
US5525348A (en) | Coating compositions comprising pharmaceutical agents | |
US8343135B2 (en) | Anti-microbial catheter | |
CH641343A5 (en) | METHOD FOR PRODUCING A TUBULAR BLOOD VESSEL PROSTHESIS AND BLOOD VESSEL PROSTHESE PRODUCED BY THE PROCESS. | |
KR101537523B1 (en) | Cannula tip for use with a vad | |
US4254180A (en) | Thrombo-resistant non-thrombogenic objects formed from resin-graphite mixtures | |
WO1988006898A1 (en) | Membrane type artificial lung and production thereof | |
US20080226694A1 (en) | Method for introducing superhydrophobic articles into the human body | |
EP0662805A1 (en) | Silicone/dacron composite vascular graft | |
JPS63172745A (en) | Hydrophilic porous polyvinylidene fluoride membrane and its production | |
US10625066B2 (en) | Vacuum assisted percutaneous appliance | |
US6833153B1 (en) | Hemocompatible coatings on hydrophobic porous polymers | |
JPS61226061A (en) | Catheter stayed in blood vessel | |
US7807210B1 (en) | Hemocompatible polymers on hydrophobic porous polymers | |
JPH06296686A (en) | Polysulfone hollow yarn membrane for medical purpose | |
AU542728B2 (en) | Check valve catheter | |
DE69318756T2 (en) | Surface treated medical devices | |
Guidoin et al. | Nature of deposits in a tubular membrane oxygenator after prolonged extracorporeal circulation: a scanning electron microscope study | |
DE3106188A1 (en) | Oxygenator membrane | |
JP2888607B2 (en) | Composite membrane for artificial lung, method for producing the same, and composite membrane-type artificial lung using the same | |
JPS58157465A (en) | Formation of porous tube product | |
Khang et al. | Prevention of platelet adhesion on polysulfone porous catheter by saline solution perfusion, II. Ex vivo and in vivo investigation | |
DE2857925C2 (en) | ||
JPS62172960A (en) | Medical materials with antithrombotic properties | |
Bambauer et al. | Scanning electron microscopic investigations of large-bore catheters used for extracorporeal detoxification methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |